Evidence map›Paper›PMID 26496686›Full record

ArticleChemistry & biology2015

Fluorinated Sterols Are Suicide Inhibitors of Ergosterol Biosynthesis and Growth in Trypanosoma brucei.

David J Leaver, Presheet Patkar, Ujjal K Singha, Matthew B Miller, Brad A Haubrich, Minu Chaudhuri, W David Nes

Abstract read
In one paragraph

Article in Chemistry & biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Steroidal Antimetabolites Protect Mice againstMolecules (Basel, Switzerland) · 2022
    Article
  4. Lipid and fatty acid metabolism in trypanosomatids.Microbial cell (Graz, Austria) · 2021
    Review
  5. Inhibition of Phytosterol Biosynthesis by Azasterols.Molecules (Basel, Switzerland) · 2020
    Article
  6. Article
  7. Article
  8. Microbial Sterolomics as a Chemical Biology Tool.Molecules (Basel, Switzerland) · 2018
    Review
  9. Review
  10. Article
  11. Lipidomics and anti-trypanosomatid chemotherapy.Clinical and translational medicine · 2017
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

David J LeaverCenter for Chemical Biology and Department of Chemistry & Biochemistry, Texas Tech University, 2500 Broadway, Lubbock, TX 79409, USA; Institute of Chemistry and Biomedical Sciences, Nanjing University, 22 Hankou Road, Nanjing, Jiangsu, 210093, P.R. China.
Presheet PatkarCenter for Chemical Biology and Department of Chemistry & Biochemistry, Texas Tech University, 2500 Broadway, Lubbock, TX 79409, USA.
Ujjal K SinghaDepartment of Microbiology and Immunology, Meharry Medical College, 1005 Doctor D. B. Todd Jr. Boulevard, Nashville, TN 37208, USA.
Matthew B MillerCenter for Chemical Biology and Department of Chemistry & Biochemistry, Texas Tech University, 2500 Broadway, Lubbock, TX 79409, USA.
Brad A HaubrichCenter for Chemical Biology and Department of Chemistry & Biochemistry, Texas Tech University, 2500 Broadway, Lubbock, TX 79409, USA.
Minu ChaudhuriDepartment of Microbiology and Immunology, Meharry Medical College, 1005 Doctor D. B. Todd Jr. Boulevard, Nashville, TN 37208, USA.
W David NesCenter for Chemical Biology and Department of Chemistry & Biochemistry, Texas Tech University, 2500 Broadway, Lubbock, TX 79409, USA. Electronic address: wdavid.nes@ttu.edu.
Texas Tech University · USMeharry Medical College · US

Funding

Mitochondrial Protein Import in Trypanosoma bruceiSC1GM081146 · NIGMS · MEHARRY MEDICAL COLLEGE · PI CHAUDHURI, MINU · 2007 to 2014
$2.6M
Discovery of New Anti-amoeba TherapeuticsR21AI119782 · NIAID · TEXAS TECH UNIVERSITY · PI NES, WILLIAM DAVID · 2015 to 2016
$447k
NIAID NIH HHS R21 AI119782NIAID NIH HHS R21AI 119782NIGMS NIH HHS GM081146NIGMS NIH HHS SC1 GM081146
6 · The paper itself

Abstract

Trypanosoma brucei, the causal agent for sleeping sickness, depends on ergosterol for growth. Here, we describe the effects of a mechanism-based inhibitor, 26-fluorolanosterol (26FL), which converts in vivo to a fluorinated substrate of the sterol C24-methyltransferase essential for sterol methylation and function of ergosterol, and missing from the human host. 26FL showed potent inhibition of ergosterol biosynthesis and growth of procyclic and bloodstream forms while having no effect on cholesterol biosynthesis or growth of human epithelial kidney cells. During exposure of cloned TbSMT to 26-fluorocholesta-5,7,24-trienol, the enzyme is gradually killed as a consequence of the covalent binding of the intermediate C25 cation to the active site (kcat/kinact = 0.26 min(-1)/0.24 min(-1); partition ratio of 1.08), whereas 26FL is non-productively bound. These results demonstrate that poisoning of ergosterol biosynthesis by a 26-fluorinated Δ(24)-sterol is a promising strategy for developing a new treatment for trypanosomiasis.

Indexed as

Antiparasitic AgentsErgosterolGas Chromatography-Mass SpectrometryHalogenationHEK293 CellsHumansMolecular StructureSterolsTrypanosoma brucei bruceiAntiparasitic AgentsErgosterolSterols

Identifiers

PMID26496686
PMCPMC4624405
OpenAlexW1876499571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.